CyberKnife SBRT, 6 years treatment results

Here is a very comprehensive report of CyberKnife treatment, side effects and biochemical control. These results may help the many now contemplating CK as their favourite choice.
Unfortunately it does not give details to distinguishing between Low, Intermediate and High risk patients but the Gleason above (4+3) 7 did worse.
6 years is a short period to evaluate the “very” late side effects, however, at 5 years it seems to be similar to the effects from High Dose Radiation Bracky Therapy (HDR BT). The conclusions on the biochemical recurrence-free survival rates was similar to the results of IMRT study published in PubMed; 5-year CK at 97% for low-risk, 90.7% for intermediate-risk, and 74.1% for high-risk patients, against 4-year IMRT at 97%, 94%, and 87% respectively. Surely the two studies cannot be compared in its whole but the population in both were more or less “homogeneous”.
Here is the CK report followed by PubMed’s study;
http://www.ro-journal.com/content/8/1/118
http://www.ncbi.nlm.nih.gov/pubmed/19445537
Regards,
VG
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 120.7K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 304 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 388 Childhood Cancers
- 27.8K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.1K Gynecological Cancers (other than ovarian and uterine)
- 12.8K Head and Neck Cancer
- 6.3K Kidney Cancer
- 659 Leukemia
- 779 Liver Cancer
- 4.1K Lung Cancer
- 5K Lymphoma (Hodgkin and Non-Hodgkin)
- 232 Multiple Myeloma
- 7.1K Ovarian Cancer
- 47 Pancreatic Cancer
- 485 Peritoneal Cancer
- 5.2K Prostate Cancer
- 1.2K Rare and Other Cancers
- 531 Sarcoma
- 706 Skin Cancer
- 642 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Other Discussion Boards